Preprint
via Europe PMC
Geriatric Assessment and Inflammaging Biomarkers in Older Patients with Urological Cancers: Evidence and a Conceptual Framework
Brumă B, Pîslaru A, Ștefăniu R, Albișteanu S, Turcu A, Grigoraș G, Lungu I, Constantinescu D, Ilie A, Alexa I.
· 2026
Abstract
<h4>Background: </h4> and Objectives: Prostate, bladder and kidney cancers are frequently diagnosed in older adults, in whom chronological age and performance status poorly reflect functional reserve. Geriatric assessment (GA) identifies clinical vulnerability, whereas the contribution of blood biomarkers of chronic low-grade inflammation (“inflammaging(definition)”) to risk stratification remains unclear. This narrative review summarizes the evidence on geriatric screening and assessment in older patients with urological cancers and on frailty-associated blood biomarkers, and asks whether these add information beyond GA. <h4>Materials and Methods:</h4> A structured, non-systematic search of PubMed/MEDLINE, Embase, Web of Science and the Cochrane Library (2010–2026) prioritized guidelines, meta-analyses and clinical studies. <h4>Results:</h4> In cohorts of mixed tumor types, the Geriatric-8 (G8) detected impairments on GA with about 82–85% sensitivity and 63–65% specificity, and an abnormal score was associated with shorter survival and more postoperative complications, including in urological cohorts. Frailty is independently associated with adverse outcomes after radical cystectomy and in renal cell carcinoma, and androgen deprivation is associated with loss of lean mass. C-reactive protein and interleukin-6 are the biomarkers most consistently associated with frailty in cross-sectional studies, but longitudinal confirmation is limited; evidence for haptoglobin and transferrin is sparse. All markers with adequate data, including the neutrophil-to-lymphocyte ratio, albumin, fibrinogen and growth differentiation factor-15, also relate to tumor stage or prognosis and are therefore non-specific. Most biomarker–frailty data come from populations without urological cancer. In a study of older patients with mixed cancer types, routine laboratory markers provided modest additional prognostic information beyond clinical variables and GA. <h4>Conclusions:</h4> The evidence reviewed does not establish an inflammaging biomarker panel sufficiently validated to guide treatment intensity in older patients with urological cancers. We outline a conceptual framework in which biomarkers form an exploratory layer added to G8 screening and GA, and identify the validation steps required before clinical use.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.20944/preprints202610.1071.v1
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
B, B., A, P., R, �., S, A., A, T., G, G., I, L., D, C., A, I., & I., A. (2026). Geriatric Assessment and Inflammaging Biomarkers in Older Patients with Urological Cancers: Evidence and a Conceptual Framework. https://doi.org/10.20944/preprints202610.1071.v1
Vancouver
B B, A P, R �, S A, A T, G G, et al. Geriatric Assessment and Inflammaging Biomarkers in Older Patients with Urological Cancers: Evidence and a Conceptual Framework. 2026. doi:10.20944/preprints202610.1071.v1.
BibTeX
@unpublished{brum2026Geriat,
title = {Geriatric Assessment and Inflammaging Biomarkers in Older Patients with Urological Cancers: Evidence and a Conceptual Framework},
author = {Brumă B and Pîslaru A and Ștefăniu R and Albișteanu S and Turcu A and Grigoraș G and Lungu I and Constantinescu D and Ilie A and Alexa I.},
year = {2026},
doi = {10.20944/preprints202610.1071.v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2012
Open access · CC-BY
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
London North West Healthcare NHS Trust 2022
Open access · US-GOV
Use of Perioperative Testosterone Replacement Therapy (TRT) in Sarcopenic Male Colorectal Cancer Patients - A Single Arm Open Label Feasibility Study
Vastra Gotaland Region 2015
Open access · US-GOV
Analysis of Sarcopenia and Body Composition in Relation to Outcome in a Cohort of Patients With Esophageal Cancer or Cancer of the Gastroesophageal Junction Before and After Surgery With Curative Intent
University of Giessen 2023
Open access · US-GOV
Multimodal Assessment of Frailty in Acute Stroke Patients Treated at a Certified Stroke-unit
Archives of Breast Cancer 2026
Open access · CC-BY
Evaluation of Association between Tumor Markers, Hormonal Receptors, Inflammatory Biomarkers and Breast Cancer
Charite University, Berlin, Germany 2016
Open access · US-GOV